Rachel Sachs Explains the FTC's Pharmacy Benefit Manager Lawsuit & PBM Reform

This episode is brought to you by Semafor Healthcare.Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.Health Affairs' Jeff Byers is joined by Deputy Editor Chris Fleming and Rachel Sachs of Washington University, St. Louis to discuss a recent lawsuit filed by the Federal Trade Commission (FTC) against the three largest pharmacy benefit managers (PBMs) in the country for rebating practices that the FTC claims resulted in inflating the list price of insulin.Health Affairs just released an Election 2024 resource hub for research and studies associated with key issues in the upcoming US presidential election. Related Articles:PBMs. What Are They Hiding? w/ Stacie Dusetzina (Health Affairs This Week)FTC sues major pharmacy benefit managers over insulin prices (Healthcare Dive)The Implications Of Rutledge v. PCMA For State Health Care Cost Regulation (Health Affairs Forefront) Subscribe to Semafor Healthcare for free.